Ramipril Recall: Check Your Medication for Affected Batch Numbers (Expiry June 2027)

by Chief Editor

Consumers who have purchased Ramipril are advised to carefully check their packaging, as multiple recent batches of the medication have been identified as potentially problematic and are subject to recall.

Ramipril Recall: What You Need to Know

“089Pharm” is recalling Ramipril 5 mg due to issues with tablet fracture resistance, according to a report from Apotheke Adhoc. The recall is currently being conducted at the wholesale and pharmacy levels, but caution is advised for all consumers. The affected packages contain 20, 50, or 100 tablets and have an expiration date through June 2027.

Did You Know? Ramipril is classified as an ACE-Hemmer, and these medications are among the most frequently prescribed drugs available.

Specifically, the recalled batches, identifiable by “Charge” or “Ch.-B.” on the packaging, are: 100425, 100625, 10125, 10425, 10625, 11024, 110425, 110625, 120425, 130425, 140425, 150425, 160425, 170425, 180425, 190425, 20625, 210425, 220425, 230425, 240425, 250425, 30425, 30625, 40425, 40625, 50425, 50625, 60425, 60625, 70425, 70625, 80425, 80625, 90425 and 90625.

While tablet fracture may seem minor, it can affect the drug’s disintegration time and the rate at which the active ingredient is released. This could mean that the medication does not work as quickly or effectively as expected.

Understanding Ramipril and ACE-Hemmers

Ramipril is a type of medication known as an ACE-Hemmer. These drugs are commonly prescribed to patients with high blood pressure, coronary heart disease, or chronic heart failure, and are often recommended following a heart attack. According to Herzmedizin, ACE-Hemmers work by preventing the activity of the Angiotensin Converting Enzyme (ACE), which narrows blood vessels and increases blood pressure.

Expert Insight: Recalls at the wholesale level are designed to prevent affected products from reaching patients. However, a quick check of your own medication is a prudent step to ensure you have a safe and effective product.

Although the recall is currently limited to wholesalers and pharmacies, checking your own Ramipril packaging is a sensible precaution.

Frequently Asked Questions

What is causing the Ramipril recall?

The recall is due to problems with the fracture resistance of the tablets, as reported by Apotheke Adhoc.

Which Ramipril batches are affected?

Batches with an expiration date through June 2027 are affected, specifically those with the following charge numbers: 100425, 100625, 10125, 10425, 10625, 11024, 110425, 110625, 120425, 130425, 140425, 150425, 160425, 170425, 180425, 190425, 20625, 210425, 220425, 230425, 240425, 250425, 30425, 30625, 40425, 40625, 50425, 50625, 60425, 60625, 70425, 70625, 80425, 80625, 90425 and 90625.

What should I do if I have a recalled batch of Ramipril?

The recall is being managed at the wholesale and pharmacy level, but it is advisable to check your packaging to confirm it is not one of the affected batches.

Given the widespread use of Ramipril for serious health conditions, how important do you think it is for patients to proactively verify their medication details?

You may also like

Leave a Comment